RNA News and Research

RSS

Ribonucleic acid (RNA) is a biologically important type of molecule that consists of a long chain of nucleotide units. Each nucleotide consists of a nitrogenous base, a ribose sugar, and a phosphate.

Viral Genetics announces effects of VGV-1 in antiretroviral non-responding HIV infections

Viral Genetics announced today that the results of a clinical trial of its investigational therapy for HIV infection, VGV-1, were recently published in a peer reviewed journal, HIV & AIDS Review.

29 Nov 2004

Research opens up new avenues to diagnosis and treat Lyme disease

Researchers at Yale School of Medicine have identified a Lyme disease receptor called TROSPA that is used by disease agents to invade ticks.

14 Nov 2004

Research aims to understand how genetic information translates into biological activity

The National Institute of Standards and Technology (NIST) has launched a new $6.25 million, five-year program to explore and address challenges in measurement, validation and quality control for the rapidly growing field of gene expression profiling.

11 Nov 2004

Crystal structure of protein AIRs kinase uncovered

Cornell University researchers, who are trying to understand how proteins evolve and function by looking at their structural features, have uncovered the crystal structure of a protein involved in making the building blocks of DNA correctly.

4 Nov 2004

Gene silencing may provide hope for leukemia sufferers

Ever since the approval of Gleevec in 2001, a cancer-cell-specific drug used to treat chronic myelogenous leukemia (CML), the field of cancer therapeutics has been rushing full speed into the era of so-called "targeted" medicines.

1 Nov 2004

Cellular enzyme represents a potential new target for developing improved HIV drugs

Scientists have discovered that a cellular enzyme helps ferry HIV genetic instructions out of the cell nucleus where they can then be translated into proteins to begin their most destructive work.

1 Nov 2004

New role for a key protein involved in muscle contraction

Overturning a scientific stereotype, researchers at the University of Illinois at Chicago have discovered a new role for a key protein involved in muscle contraction and shown it is present not just in the cytoplasm of cells but in the nucleus as well.

1 Nov 2004

Routine screening of blood samples would reduce the risk of disease transmission among transplant recipients

Results of a study in this week’s issue of THE LANCET suggest that routine screening of blood samples to detect viral RNA among organ and tissue donors who do not have obvious signs of clinical disease would reduce the risk of disease transmission among transplant recipients.

29 Oct 2004

Micro-array technology is revolutionising current drug development

Gene expression micro-array technology is benefiting all phases of the discovery, development and subsequent use of new cancer therapeutics

29 Oct 2004

Study could lead to new, more effective treatments for urinary tract infections

Anyone who thinks scientists lead a glamorous, exciting life should talk to Jennifer Snyder, a graduate student at the University of Maryland’s School of Medicine.

25 Oct 2004

A single change in a person’s DNA can contribute to a range of life-shortening risk factors

A woman with hypertension, low magnesium levels, and a cooperative family allowed scientists to pinpoint the mutation, which affects the genes of the mitochondria — the energy-producing power plants of the cell that are passed from mother to offspring.

25 Oct 2004

Blocking gene opens avenues for treating prostate cancer

Cancer Research UK scientists in Oxford have found a new way to make prostate cancer succumb more readily to currently used treatments.

22 Oct 2004

Detecting diseases with no more to work with than a drop of blood

The dream of monitoring a patient's physical condition through blood testing has long been realized. But how about detecting diseases in their very early stages, or evaluating how they are responding to treatment, with no more to work with than a drop of blood!

22 Oct 2004

Researchers have developed a novel drug-antidote pair

In a discovery that could give physicians more control over the actions of medications, researchers at Duke University Medical Center have developed a novel drug pair – a potent anti-coagulant with a matched "antidote."

18 Oct 2004

Researchers have identified a protein in the inner ear that translates sound into the nerve impulses used by the brain

Researchers at Harvard Medical School and their colleagues report in the October 13 Nature advanced on-line edition that they have identified a protein deep in the inner ear that they believe translates sound into the nerve impulses used by the brain.

13 Oct 2004

Discovery of naturally occurring RNA "switches" that manage the amino acid glycine

Two University of Washington computer scientists are part of a team that has discovered a pair of rare, naturally occurring RNA "switches" in a class of bacteria that work cooperatively to manage the amino acid glycine.

11 Oct 2004

Discovery could lead to the creation of naturally decaffeinated coffee plants

Chemists at Emory University have made an important advance in harnessing the ability of bacteria to make new molecules, and their discovery could eventually lead to the creation of naturally decaffeinated coffee plants.

10 Oct 2004

Researchers have found a starting point to establishing the genetic basis for sinus disease

In a three-year analysis of more than 10,500 genes, one-third of the human genome, researchers at Johns Hopkins have found a starting point to establishing the genetic basis for sinus disease and the growth of nasal polyps, illnesses not well understood despite their prevalence.

8 Oct 2004

Influenza is a contagious disease caused by an RNA virus of the orthomyxoviridae family

Influenza (or as it is commonly known, the flu) is a contagious disease caused by an RNA virus of the orthomyxoviridae family (The orthomyxoviridae is a family of RNA viruses which infect vertebrate).

6 Oct 2004

RiboNovix secures license to novel anti-infective discovery technology from Wayne State University

New biotechnology company, RiboNovix, Inc., is addressing the worsening problem of antibiotic-resistant bacteria by developing new anti-infectives that are less susceptible to drug resistance.

5 Oct 2004

RNA News and Research

Further Reading

Viral Genetics announces effects of VGV-1 in antiretroviral non-responding HIV infections

Research opens up new avenues to diagnosis and treat Lyme disease

Research aims to understand how genetic information translates into biological activity

Crystal structure of protein AIRs kinase uncovered

Gene silencing may provide hope for leukemia sufferers

Cellular enzyme represents a potential new target for developing improved HIV drugs

New role for a key protein involved in muscle contraction

Routine screening of blood samples would reduce the risk of disease transmission among transplant recipients

Micro-array technology is revolutionising current drug development

Study could lead to new, more effective treatments for urinary tract infections

A single change in a person’s DNA can contribute to a range of life-shortening risk factors

Blocking gene opens avenues for treating prostate cancer

Detecting diseases with no more to work with than a drop of blood

Researchers have developed a novel drug-antidote pair

Researchers have identified a protein in the inner ear that translates sound into the nerve impulses used by the brain

Discovery of naturally occurring RNA "switches" that manage the amino acid glycine

Discovery could lead to the creation of naturally decaffeinated coffee plants

Researchers have found a starting point to establishing the genetic basis for sinus disease

Influenza is a contagious disease caused by an RNA virus of the orthomyxoviridae family

RiboNovix secures license to novel anti-infective discovery technology from Wayne State University

Discover how SciY empowers scientists

Why use light scattering to analyze proteins and viral vectors?

Changing the landscape of R&D to build clinical success from the ground up

Latest Life Science News